| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-10 01:49:04 UTC |
|---|
| Updated at | 2022-09-10 01:49:04 UTC |
|---|
| NP-MRD ID | NP0293681 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (2r,3r,4s,5r,6r)-2-{[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(2e)-2-methylbut-2-enoyl]oxy}oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl (2e)-2-methylbut-2-enoate |
|---|
| Description | Trehangelin belongs to the class of organic compounds known as saccharolipids. Saccharolipids are compounds in which fatty acids are linked directly to a sugar backbone, forming structures that are compatible with membrane bilayers. In the saccharolipids, a sugar substitutes for the glycerol backbone that is present in glycerolipids and glycerophospholipids. The most familiar saccharolipids contain an acylated glucosamine. In contrast to others glycolipids, the fatty acid is not glycosidically linked to the sugar moiety. (2r,3r,4s,5r,6r)-2-{[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(2e)-2-methylbut-2-enoyl]oxy}oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl (2e)-2-methylbut-2-enoate is found in Polymorphospora rubra. (2r,3r,4s,5r,6r)-2-{[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(2e)-2-methylbut-2-enoyl]oxy}oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl (2e)-2-methylbut-2-enoate was first documented in 2013 (PMID: 23591606). Based on a literature review a small amount of articles have been published on Trehangelin (PMID: 32620362) (PMID: 31787724) (PMID: 35322208) (PMID: 27311629). |
|---|
| Structure | C\C=C(/C)C(=O)O[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](OC(=O)C(\C)=C\C)[C@H]2O)[C@H](O)[C@H]1O InChI=1S/C22H34O13/c1-5-9(3)19(29)33-18-13(25)11(7-23)31-22(16(18)28)34-17-12(8-24)32-21(15(27)14(17)26)35-20(30)10(4)6-2/h5-6,11-18,21-28H,7-8H2,1-4H3/b9-5+,10-6+/t11-,12-,13-,14-,15-,16-,17-,18+,21-,22-/m1/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C22H34O13 |
|---|
| Average Mass | 506.5010 Da |
|---|
| Monoisotopic Mass | 506.19994 Da |
|---|
| IUPAC Name | (2R,3R,4S,5R,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(2E)-2-methylbut-2-enoyl]oxy}oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl (2E)-2-methylbut-2-enoate |
|---|
| Traditional Name | (2R,3R,4S,5R,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(2E)-2-methylbut-2-enoyl]oxy}oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl (2E)-2-methylbut-2-enoate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | C\C=C(/C)C(=O)O[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](OC(=O)C(\C)=C\C)[C@H]2O)[C@H](O)[C@H]1O |
|---|
| InChI Identifier | InChI=1S/C22H34O13/c1-5-9(3)19(29)33-18-13(25)11(7-23)31-22(16(18)28)34-17-12(8-24)32-21(15(27)14(17)26)35-20(30)10(4)6-2/h5-6,11-18,21-28H,7-8H2,1-4H3/b9-5+,10-6+/t11-,12-,13-,14-,15-,16-,17-,18+,21-,22-/m1/s1 |
|---|
| InChI Key | OTULWMXLCWGWNJ-HVMOYWOSSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as saccharolipids. Saccharolipids are compounds in which fatty acids are linked directly to a sugar backbone, forming structures that are compatible with membrane bilayers. In the saccharolipids, a sugar substitutes for the glycerol backbone that is present in glycerolipids and glycerophospholipids. The most familiar saccharolipids contain an acylated glucosamine. In contrast to others glycolipids, the fatty acid is not glycosidically linked to the sugar moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Saccharolipids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Saccharolipids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Saccharolipid
- O-glycosyl compound
- Glycosyl compound
- Disaccharide
- Fatty acid ester
- Fatty acyl
- Oxane
- Dicarboxylic acid or derivatives
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Secondary alcohol
- Carboxylic acid ester
- Oxacycle
- Organoheterocyclic compound
- Carboxylic acid derivative
- Acetal
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Primary alcohol
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Nakashima T, Okuyama R, Kamiya Y, Matsumoto A, Iwatsuki M, Inahashi Y, Yamaji K, Takahashi Y, Omura S: Trehangelins A, B and C, novel photo-oxidative hemolysis inhibitors produced by an endophytic actinomycete, Polymorphospora rubra K07-0510. J Antibiot (Tokyo). 2013 Jun;66(6):311-7. doi: 10.1038/ja.2013.17. Epub 2013 Apr 17. [PubMed:23591606 ]
- Ishikawa H, Ino S, Nakashima T, Matsuo H, Takahashi Y, Kohda C, Omura S, Iyoda M, Tanaka K: Oral administration of trehangelin-A alleviates metabolic disorders caused by a high-fat diet through improvement of lipid metabolism and restored beneficial microbiota. Obes Res Clin Pract. 2020 Jul - Aug;14(4):360-367. doi: 10.1016/j.orcp.2020.06.004. Epub 2020 Jul 1. [PubMed:32620362 ]
- Ishikawa H, Ino S, Nakashima T, Matsuo H, Takahashi Y, Kohda C, Omura S, Tanaka K: Improvement Effects of Trehangelin A on High-Fat Diet Causing Metabolic Clinical Conditions. Biol Pharm Bull. 2019;42(12):2095-2101. doi: 10.1248/bpb.b19-00668. [PubMed:31787724 ]
- Lu S, Harunari E, Oku N, Igarashi Y: Trehangelin E, a bisacyl trehalose with plant growth promoting activity from a rare actinomycete Polymorphospora sp. RD064483. J Antibiot (Tokyo). 2022 May;75(5):296-300. doi: 10.1038/s41429-022-00519-5. Epub 2022 Mar 23. [PubMed:35322208 ]
- Inahashi Y, Shiraishi T, Palm K, Takahashi Y, Omura S, Kuzuyama T, Nakashima T: Biosynthesis of Trehangelin in Polymorphospora rubra K07-0510: Identification of Metabolic Pathway to Angelyl-CoA. Chembiochem. 2016 Aug 3;17(15):1442-7. doi: 10.1002/cbic.201600208. Epub 2016 Jun 17. [PubMed:27311629 ]
- LOTUS database [Link]
|
|---|